Guided Therapeutics, Inc.
General ticker "GTHP" information:
- Sector: Health Care
- Industry: Health Care Equipment & Supplies
- Capitalization: $12.3M (TTM average)
Guided Therapeutics, Inc. follows the US Stock Market performance with the rate: 39.4%.
Estimated limits based on current volatility of 3.5%: low 0.24$, high 0.26$
Factors to consider:
- Total employees count: 4 (-33.3%) as of 2023
- Top business risk factors: Insufficient funding, Geopolitical risks, Regulatory and compliance, Market acceptance, Supply chain disruptions
- Price in estimated range
- Earnings for 9 months up through Q3 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2024-12-31 to 2026-12-31
- 2024-12-31 to 2025-12-31 estimated range: [0.11$, 0.31$]
- 2025-12-31 to 2026-12-31 estimated range: [0.08$, 0.26$]
Financial Metrics affecting the GTHP estimates:
- Positive: with PPE of -3.1 at the end of fiscal year the price was low
- Negative: negative Operating income
- Negative: Operating cash flow per share per price, % of -12.79 <= 0.33
- Negative: negative Industry operating cash flow (median)
- Negative: negative Net income
- Positive: Investing cash flow per share per price, % of 0 > -0.66
- Negative: Shareholder equity ratio, % of -354.79 <= 18.93
- Positive: Industry inventory ratio change (median), % of -1.44 <= -0.15
Short-term GTHP quotes
Long-term GTHP plot with estimates
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.01MM | $0.10MM | $0.01MM |
| Operating Expenses | $3.35MM | $3.56MM | $2.12MM |
| Operating Income | $-3.33MM | $-3.46MM | $-2.11MM |
| Non-Operating Income | $-1.01MM | $-0.03MM | $-0.31MM |
| Interest Expense | $0.58MM | $0.28MM | $0.38MM |
| R&D Expense | $0.08MM | $0.23MM | $0.53MM |
| Income(Loss) | $-4.34MM | $-3.49MM | $-2.42MM |
| Profit(Loss)* | $-4.34MM | $-3.49MM | $-2.42MM |
| Stockholders Equity | $-2.88MM | $-3.81MM | $-4.89MM |
| Inventory | $0.55MM | $0.63MM | $0.63MM |
| Assets | $3.37MM | $1.67MM | $1.38MM |
| Operating Cash Flow | $-1.48MM | $-1.75MM | $-1.12MM |
| Capital expenditure | $0.03MM | $0.00MM | $0.00MM |
| Investing Cash Flow | $-0.03MM | $0.00MM | $0.00MM |
| Financing Cash Flow | $3.18MM | $0.02MM | $0.92MM |
| Earnings Per Share** | $-0.13 | $-0.07 | $-0.04 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.